UTAH MEDICAL PRODUCTS, INC. Current Assets
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Current Assets of $100.64 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $100.64M.
- 2026-03-31: Assets, Current $100.38M.
- 2025-12-31: Assets, Current $97.74M.
- 2025-09-30: Assets, Current $96.53M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $100.64M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $100.38M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $97.74M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $96.53M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $94.38M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $96.40M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $96.33M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $101.66M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $102.32M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $107.15M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $106.27M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $101.85M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $98.81M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $95.11M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $89.92M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $84.24M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $78.95M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $79.48M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $73.16M 10-K/A · filed 2023-03-28 | |
| 2021-09-30 | $75.85M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $70.59M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $66.62M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $62.26M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $57.26M 10-Q/A · filed 2020-11-09 | |
| 2020-06-30 | $53.12M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $51.22M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $54.89M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $49.51M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $46.23M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $45.67M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $60.90M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $59.05M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $56.00M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $53.12M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $49.19M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $48.02M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $43.79M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $40.52M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $34.47M 10-K · filed 2018-03-06 | $34.87M 10-K · filed 2017-03-08 |
| 2016-09-30 | $41.90M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $39.22M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $38.27M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $32.87M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $32.31M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $29.98M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $26.79M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $29.68M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $28.58M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $27.42M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $26.33M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $24.29M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $24.53M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $22.29M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $21.60M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $18.54M 10-K · filed 2014-03-12 | |
| 2012-09-30 | $20.06M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $18.65M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $19.99M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $17.02M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $17.74M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $17.06M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $25.14M 10-K/A · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |